Psychoeducation of Parents to Children With FASD
NorFASDPEdu
Evaluation of a Treatment Program Based on Psychoeducation of Parents of Children and Adolescents With Fetal Alcohol Spectrum Disorder (FASD)
1 other identifier
interventional
75
1 country
1
Brief Summary
By longitudinal, prospective research in children and adolescents with Fetal Alcohol Spectrum Disorders (FASD) and their parents to explore the beneficial effects of participating in a standardized intervention program in order to treat and reduce the consequences of early brain damage. By using elements from international programs based on psychoeducation and parent training, the investigators aim to help parents to better understand and respond to the neurodevelopmental disabilities of their children, and thereby improving behavioral problems and self-regulation deficits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 2, 2023
CompletedFirst Posted
Study publicly available on registry
January 17, 2023
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
May 21, 2025
May 1, 2025
1.6 years
January 2, 2023
May 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The Children's Global Assessment Scale (CGAS)
To evaluate effects of the intervention program well-known standardized, validated measures will be used. Primary outcome measure for the child will be The Children's Global Assessment Scale, which is a numeric scale used by mental health clinicians to rate the general functioning of youths under the age of 18. The scale targets the number of behavioral problems and the frequency of their occurrence.The child or young person is given a single score between 1 and 100. Higher score means better functioning.
up to 10 months
The Family Empowerment Scale (FES)
Primary outcome measure for parents will be The Family Empowerment Scale to evaluate the magnitude of empowerment in the parent-child system. FES is a 34-item rating scale where the participants rate each item on a 5-point Likert-type rating scale. Scores will range between 34 and 170 points. Increasing scores indicate a positive significance regarding family empowerment.
up to 10 months
Secondary Outcomes (4)
The Eyberg Child Behavior Inventory (ECBI)
up to 10 months
The Social Responsiveness Scale, Second Edition (SRS-2)
up to 10 months
The Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2)
up to 10 months
The Parenting Stress Index (PSI)
up to 10 months
Study Arms (1)
Patient group
EXPERIMENTALSingle arm study. The family with child with FASD will act as its own control in the period before intervention starts.
Interventions
The program consists of a standardized manual-based treatment package as an easily accessible treatment tool for use by professionals in the specialist health services, who have treatment responsibilities for children diagnosed with FASD in Norway. The intervention program will last for about 2 months and includes eight sessions, including six digitally based, interactive psychoeducational sessions. Topics will be: 1. General information about FASD 2. Intervention strategies in kindergartens/schools for children with FASD 3. Families living with FASD - activities of daily living 4. Self-regulatory deficits - how to cope 5. Executive functions in daily life 6. Social development in children with FASD 7. Guidance in social settings 8. Challenging behavior - what can be done
Eligibility Criteria
You may not qualify if:
- Children with known genetic syndromes, progressive brain and neuromuscular diseases or major sensory defects (blindness or deafness).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sørlandet Hospital
Arendal, 4809, Norway
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jon S Skranes, Dr Med
Sørlandet Hospital HF
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 2, 2023
First Posted
January 17, 2023
Study Start
May 1, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
May 21, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share